TOKYO -- Takeda Pharmaceutical has high hopes for China, India and Southeast Asia, as Japan's largest drugmaker looks to further extend its international reach, CEO Christophe Weber said in an interview on Tuesday.
Global Management Forum 2019
Takeda focuses on 'high priority' Asia after huge bet on Shire
Drugmaker taking break from acquisitions but wants partners, CEO Weber says
Takeda Pharmaceutical President and CEO Christophe Weber speaks to the Nikkei Asian Review on the sidelines of the Nikkei Global Management Forum on Oct. 29 in Tokyo. (Photo by Shihoko Nakaoka)
Read Next
Latest on Global Management Forum 2019
